When Costs Shift, Trust Is On The Line: How Agencies Can Lead Through Medicare’s 2026 Changes
Angela Palo is COO of Pinnacle Financial Services, a leading National Medicare Brokerage, and a member of the NABIP Medicare FMO Council.
As 2026 unfolds, many Americans with Medicare are realizing something has changed.
Not because they followed policy updates or tracked regulatory headlines. They’ve noticed it when prescription costs have shown up differently than they expected. Payments feel spread out. Deductibles feel more visible. Some medications cost less. Others don’t.
That moment is where leadership shows up. In my experience, it’s also the moment that separates prepared agencies from reactive ones.
Licensed agents field the questions. Agencies either reinforce trust or quietly lose it. The difference doesn’t come down to how much people pay overall, but how clearly professionals explain what individuals are experiencing and why.
I think the agencies that succeed in 2026 won’t chase headlines about cost relief; they’ll focus on clarity, consistency, and expectation setting. That’s where long-term confidence is built. Affordability is measured as much in trust as it is in dollars.
The affordability story isn’t one-dimensional anymore.
The introduction of a $2,100 annual out-of-pocket cap for Part D prescription drugs is one of the most meaningful changes beneficiaries have experienced thus far in 2026. Once individuals reach that threshold, they won’t pay copayments or coinsurance for covered Part D medications for the rest of the year.
That cap matters. But it doesn’t tell the whole story.
Deductibles can still reach up to $615 in 2026, and cost-sharing remains front-loaded for many plans. At the same time, average premiums for stand-alone drug plans are declining in many states, even as overall plan availability continues to narrow.
For many Americans, this creates a disconnect, not because protections don’t exist, but because trust gets tested when expectations and experience don’t line up. From what I’ve seen, it’s one of the most common sources of frustration this year. Total annual exposure is limited, yet early costs can still feel sharp. Without context, people may assume something went wrong or that they chose poorly.
Strong agencies will anticipate that confusion and address it before frustration sets in.
Affordability has become a trust question.
One of the most underutilized changes shaping Part D in 2026 is the Medicare Prescription Payment Plan. This option allows beneficiaries to spread their out-of-pocket prescription costs across the year instead of paying larger amounts at the pharmacy counter. All Part D plans are required to offer it.
This program doesn’t reduce total drug costs. It changes how and when those costs are paid. That distinction is important, because when people don’t understand timing, they don’t lose money first. They lose confidence. When licensed agents explain it clearly, individuals see it as a budgeting tool. But when it’s oversold, disappointment follows.
I’ve noticed early participation has been limited, largely because many people don’t yet understand when the option makes sense. That confusion often has far less to do with resistance and far more to do with unclear explanations. That gap is an educational opportunity.
Agencies that equip agents to walk through payment timing calmly and honestly can elevate the professional relationship. They can help people feel informed instead of reactive, which is exactly what trust looks like in practice.
Savings exist, but expectations still need guardrails.
Some beneficiaries have also benefited directly from the first round of negotiated drug prices, taking effect in 2026 for a limited group of high-cost medications. These negotiations reduce out-of-pocket spending for certain widely used drugs, particularly those treating chronic conditions.
That progress deserves recognition, but it also requires precision.
Not every medication qualifies. Not every individual sees the same result. When agents explain this nuance clearly, people trust the guidance. When people hear only the headline, expectations can quickly outpace reality.
Thought leadership in this moment means helping professionals balance optimism with accuracy. It means guiding conversations without exaggeration and reinforcing that coverage decisions are personal, not one-size-fits-all.
What are high-performing agencies doing differently?
I think the most effective agencies will treat early 2026 as an extension of service, not a reset after enrollment. They’ll focus on preparation, not damage control.
Trust can be built or broken in the small moments when people are trying to make sense of what they’re experiencing. In practice, that leadership mindset shows up in three consistent ways:
1. They train agents to explain cost timing, not just total cost. People often feel calmer when they understand why early-year expenses look different, even when annual exposure is capped.
2. They position payment options as tools rather than savings guarantees. In my experience, the Medicare Prescription Payment Plan works best when framed as a budgeting choice, not a promise of lower costs.
3. They stay visible after coverage begins. A proactive check-in reinforces that the relationship extends beyond enrollment and helps resolve questions before frustration takes hold.
These agencies understand something critical: Affordability has a lot to do with confidence.
They also understand that confusion, left unaddressed, erodes trust. I’ve seen it happen long before a complaint is ever voiced. By the time an individual voices concern, confidence has often already slipped. Being a strong leader means getting ahead of that moment.
Leadership lives in the explanation.
Part D in 2026 doesn’t call for louder messaging or faster answers. It calls for better guidance. As cost structures shift and new options reshape how people experience coverage, clarity becomes the differentiator.
Licensed agents remain trusted interpreters of Medicare’s complexity. Agencies that invest in training, structure, and clear expectations strengthen that trust at scale and equip their teams to lead with confidence, not urgency.
Medicare will continue to evolve, and affordability conversations will only grow more nuanced. That’s exactly why leadership matters now. Agencies that choose preparation over reaction and education over urgency can stand apart. They’ll show Americans that guidance can feel steady, transparent, and human, even in times of change. When guidance feels steady, confidence follows.
Angela Palo
Chief Operating Officer
Executive VP
